Design and synthesis of a peptide-PEG transporter tool for carrying adenovirus vector into cells

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 3, 2005, Pages 621-624

  Maeda, Mitsuko ^a   Kida, Shinya ^a   Hojo, Keiko ^a   Eto, Yusuke ^b   Gaob, Jian Qing ^b   Kurachi, Shinnosuke ^b   Sekiguchi, Fumiko ^b   Mizuguchi, Hiroyuki ^c   Hayakawa, Takao ^c   Mayumi, Tadanori ^a   Nakagawa, Shinsaku ^b   Kawasaki, Koichi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Adenovirus vector; Peptide synthesis; Poly(ethylene glycol); RGD; Transduction

Indexed keywords

(ACETYLTYROSYLGLYCYLGLYCYLARGINYLGLYCYLASPARTYLTHREONYLPROLYL BETA ALANYL) 2 LYSYLPOLYETHYLENE GLYCOL ALANYLCYSTEINAMIDE; 6 [(ACETYLTYROSYLGLYCYLGLYCYLARGINYLGLYCYLASPARTYLTHREONYLPROLYL BETA ALANYL) 2 LYSYLPOLYETHYLENE GLYCOL ALANYLCYSTEINAMIDE SUCCINIMIDO]HEXANOIC ACID N HYDROXYSUCCINIMIDE ESTER; 6 MALEIMIDOHEXANOIC ACID N HYDROXYSUCCINIMIDE ESTER; ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; HEXANOIC ACID DERIVATIVE; INTEGRIN; MACROGOL; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SYNTHESIS; GENE EXPRESSION; GENETIC TRANSFECTION; RISK ASSESSMENT;

ADENOVIRIDAE; AMINO ACID SEQUENCE; CELL LINE; DRUG CARRIERS; DRUG DESIGN; GENE EXPRESSION; GENETIC VECTORS; HUMANS; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

ADENOVIRIDAE;

EID: 19944430495     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.11.055     Document Type: Article

References (19)

1. This paper was reported at The 123rd Annual Meeting of The Pharmaceutical Society of Japan, Nagasaki, Japan, Mar 27-29, 2003
2. R.G. Crystal Science 270 1955 404 4010
3. J.M. Wilson New Engl. J. Med. 334 1996 1185
4. J.M. Bergelson, J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, J.S. Hong, M.S. Horwitz, R.L. Crowell, and R.W. Finberg Science 275 1997 1320
5. M.C. Bewley, K. Springer, Y.B. Zhang, P. Freimuth, and J.M. Flanagan Science 286 1999 1579
6. T.J. Wickham, P. Mathias, D.A. Cheresh, and G.R. Nemerow Cell 73 1993 309 319
7. M. Bai, B. Harfe, and P. Freimuth J. Virol. 67 1993 5198
8. F.W. Van Ginkel, C.-G. Liu, J.W. Simecka, J.-Y. Dong, T. Greenway, R.A. Frizzell, H. Kiyono, J.R. McGhee, and D.W. Pascual Hum. Gene Ther. 6 1995 895
9. H. Romanczuk, C.D. Galer, J. Zabner, G. Barsomian, S.C. Wadsworth, and C.R. O'Riordan Hum. Gene Ther. 1 1999 2615
10. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson J. Viol. 75 2001 4792
11. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson Hum. Gene Ther. 10 2002 1887
12. Y. Eto, J. Gao, F. Sekiguchi, S. Kurachi, K. Katayama, H. Mizuguchi, T. Hayakawa, Y. Tsutsumi, T. Mayumi, and S. Nakagawa Biol. Pharm. Bull. 27 2004 936
13. P. Erbacher, J.S. Remy, and J.P. Behr Gene Ther. 6 1999 138
14. S. Hashida, M. Imagawa, S. Inoue, K.H. Ruan, and E. Ishikawa J. Appl. Biochem. 6 1984 53
15. C. Fargeas, M. Hommel, R. Maingon, C. Dourado, M. Monsigny, and R. Mayer J. Clin. Microbiol. 2 1996 241
16. H. Rink Tetrahedron Lett. 28 1987 3787
17. M.S. Bernatowicz, S.B. Daniels, and H. Köster Tetrahedron Lett. 30 1989 4645
18. 2 content of the used resin). Amino acid ratios in an acid hydrolysate: Asp, 0.80; Gly, 3.21; Arg, 0.87; Thr, 1.06; Pro, 1.02; Tyr, 0.91; Lys, 0.50. Peptide content calculated from the amino acid analysis, 0.15 mmol/g
19. K. Ogawara, M.G. Rots, R.J. Kok, H.E. Moorlag, A.V. Loenen, D.K.F. Meijer, H.J. Haisma, and G. Molema Human Gene Ther. 15 2004 433